1. Home
  2. MRVI vs BAK Comparison

MRVI vs BAK Comparison

Compare MRVI & BAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$7.29

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Braskem SA ADR

BAK

Braskem SA ADR

N/A

Current Price

$1.79

Market Cap

900.6M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
MRVI
BAK
Founded
2014
1972
Country
United States
Brazil
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
900.6M
IPO Year
2020
2002

Fundamental Metrics

Financial Performance
Metric
MRVI
BAK
Price
$7.29
$1.79
Analyst Decision
Buy
Hold
Analyst Count
4
2
Target Price
$4.13
$4.40
AVG Volume (30 Days)
4.6M
2.7M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$12.54
$16.02
Revenue Next Year
$7.87
$7.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$1.40
52 Week High
$9.42
$5.40

Technical Indicators

Market Signals
Indicator
MRVI
BAK
Relative Strength Index (RSI) 47.43 42.05
Support Level $5.54 $1.40
Resistance Level $7.44 $3.14
Average True Range (ATR) 0.33 0.14
MACD -0.14 0.04
Stochastic Oscillator 17.23 45.30

Price Performance

Historical Comparison
MRVI
BAK

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About BAK Braskem SA ADR

Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.

Share on Social Networks: